146 related articles for article (PubMed ID: 37862818)
1. Discovery of novel amidobenzimidazole derivatives as orally available small molecule modulators of stimulator of interferon genes for cancer immunotherapy.
Jeon MJ; Lee H; Jo S; Kang M; Jeong JH; Jeong SH; Lee JY; Song GY; Choo H; Lee S; Kim H
Eur J Med Chem; 2023 Dec; 261():115834. PubMed ID: 37862818
[TBL] [Abstract][Full Text] [Related]
2. Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor.
Chen NN; Zhang H; Zhu QS; Zeng T; Dai W; Zhou YL; Xin GF; Wu BD; Gong SJ; Jiang ZY; You QD; Xu XL
J Med Chem; 2023 Apr; 66(8):5584-5610. PubMed ID: 37027512
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists.
Liu X; Wang M; Yang M; Sun H; Wang B; Pan X; Chen X; Jin J; Wang X
Eur J Med Chem; 2023 Jan; 246():114943. PubMed ID: 36462438
[TBL] [Abstract][Full Text] [Related]
4. Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor.
Jeon MJ; Lee H; Lee J; Baek SY; Lee D; Jo S; Lee JY; Kang M; Jung HR; Han SB; Kim NJ; Lee S; Kim H
J Med Chem; 2022 Apr; 65(7):5407-5432. PubMed ID: 35315650
[TBL] [Abstract][Full Text] [Related]
5. Structure-Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists.
Shen A; Li X; Zhang Y; Ma J; Xiao R; Wang X; Song Z; Liu Z; Geng M; Zhang A; Xie Z; Ding C
Eur J Med Chem; 2022 Nov; 241():114627. PubMed ID: 35963129
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.
Niu J; Bai H; Li Z; Gao Y; Zhang Y; Wang X; Yang Y; Xu Y; Geng M; Xie Z; Zhou B
Eur J Med Chem; 2022 Aug; 238():114482. PubMed ID: 35671593
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.
Xi Q; Wang M; Jia W; Yang M; Hu J; Jin J; Chen X; Yin D; Wang X
J Med Chem; 2020 Jan; 63(1):260-282. PubMed ID: 31820985
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents.
Feng X; Pan L; Qian Z; Liu D; Guan X; Feng L; Song B; Xu X; Tan N; Ma Y; Li Z; Wang Z; Bian J
J Med Chem; 2022 Nov; 65(22):15048-15065. PubMed ID: 36069713
[TBL] [Abstract][Full Text] [Related]
9. Chemical Biology Perspectives on STING Agonists as Tumor Immunotherapy.
Xuan C; Hu R
ChemMedChem; 2023 Dec; 18(23):e202300405. PubMed ID: 37794702
[TBL] [Abstract][Full Text] [Related]
10. M335, a novel small-molecule STING agonist activates the immune response and exerts antitumor effects.
Zhao M; Fan W; Wang Y; Qiang P; Zheng Z; Shan H; Zhang M; Liu P; Wang Y; Li G; Li M; Hong L
Eur J Med Chem; 2024 Jan; 264():116018. PubMed ID: 38091891
[TBL] [Abstract][Full Text] [Related]
11. TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies.
Carideo Cunniff E; Sato Y; Mai D; Appleman VA; Iwasaki S; Kolev V; Matsuda A; Shi J; Mochizuki M; Yoshikawa M; Huang J; Shen L; Haridas S; Shinde V; Gemski C; Roberts ER; Ghasemi O; Bazzazi H; Menon S; Traore T; Shi P; Thelen TD; Conlon J; Abu-Yousif AO; Arendt C; Shaw MH; Okaniwa M
Cancer Res Commun; 2022 Jun; 2(6):489-502. PubMed ID: 36923556
[TBL] [Abstract][Full Text] [Related]
12. STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway.
Yin M; Hu J; Yuan Z; Luo G; Yao J; Wang R; Liu D; Cao B; Wu W; Hu Z
Cell Cycle; 2022 Apr; 21(8):767-779. PubMed ID: 35130108
[TBL] [Abstract][Full Text] [Related]
13. Unlocking the promise of systemic STING agonist for cancer immunotherapy.
Sun X; Zhou X; Lei YL; Moon JJ
J Control Release; 2023 May; 357():417-421. PubMed ID: 37001564
[TBL] [Abstract][Full Text] [Related]
14. Structure-Activity Relationship Study of Amidobenzimidazole Analogues Leading to Potent and Systemically Administrable Stimulator of Interferon Gene (STING) Agonists.
Song Z; Wang X; Zhang Y; Gu W; Shen A; Ding C; Li H; Xiao R; Geng M; Xie Z; Zhang A
J Med Chem; 2021 Feb; 64(3):1649-1669. PubMed ID: 33470814
[TBL] [Abstract][Full Text] [Related]
15. STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors.
Perera SA; Kopinja JE; Ma Y; Muise ES; Laskey J; Chakravarthy K; Chen Y; Cui L; Presland J; Sathe M; Javaid S; Minnihan EC; Ferguson HM; Piesvaux J; Pan BS; Zhao S; Sharma SK; Woo HC; Pucci V; Knemeyer I; Cemerski S; Cumming J; Trotter BW; Tse A; Khilnani A; Ranganath S; Long BJ; Bennett DJ; Addona GH
Mol Cancer Ther; 2022 Feb; 21(2):282-293. PubMed ID: 34815361
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.
Abraham J; Botto S; Mizuno N; Pryke K; Gall B; Boehm D; Sali TM; Jin H; Nilsen A; Gough M; Baird J; Chakhtoura M; Subra C; Trautmann L; Haddad EK; DeFilippis VR
Front Immunol; 2020; 11():1430. PubMed ID: 32733475
[TBL] [Abstract][Full Text] [Related]
17. Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020).
Chen NN; Zhang H; You QD; Xu XL
Expert Opin Ther Pat; 2021 Jun; 31(6):563-584. PubMed ID: 33459063
[TBL] [Abstract][Full Text] [Related]
18. Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy.
Dejmek M; Brazdova A; Otava T; Polidarova MP; Klíma M; Smola M; Vavrina Z; Buděšínský M; Dračínský M; Liboska R; Boura E; Birkuš G; Nencka R
Eur J Med Chem; 2023 Nov; 259():115685. PubMed ID: 37567057
[TBL] [Abstract][Full Text] [Related]
19. Design of amidobenzimidazole STING receptor agonists with systemic activity.
Ramanjulu JM; Pesiridis GS; Yang J; Concha N; Singhaus R; Zhang SY; Tran JL; Moore P; Lehmann S; Eberl HC; Muelbaier M; Schneck JL; Clemens J; Adam M; Mehlmann J; Romano J; Morales A; Kang J; Leister L; Graybill TL; Charnley AK; Ye G; Nevins N; Behnia K; Wolf AI; Kasparcova V; Nurse K; Wang L; Puhl AC; Li Y; Klein M; Hopson CB; Guss J; Bantscheff M; Bergamini G; Reilly MA; Lian Y; Duffy KJ; Adams J; Foley KP; Gough PJ; Marquis RW; Smothers J; Hoos A; Bertin J
Nature; 2018 Dec; 564(7736):439-443. PubMed ID: 30405246
[TBL] [Abstract][Full Text] [Related]
20. Rationale for stimulator of interferon genes-targeted cancer immunotherapy.
Rivera Vargas T; Benoit-Lizon I; Apetoh L
Eur J Cancer; 2017 Apr; 75():86-97. PubMed ID: 28219022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]